U.S. Markets closed

Albany Molecular Research, Inc. (AYM.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
15.525+0.26 (+1.70%)
At close: 3:35PM CEST
Interactive chart
Previous Close15.266
Bid15.560 x 26300
Ask15.870 x 25300
Day's Range15.382 - 15.525
52 Week Range11.708 - 17.960
Avg. Volume18
Market Cap671.99M
PE Ratio (TTM)-8.82
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Associated Press14 days ago

    Albany Molecular Research posts 1Q loss

    The Albany, New York-based company said it had a loss of 25 cents per share. Earnings, adjusted for one-time gains and costs, came to 13 cents per share. The results beat Wall Street expectations. The ...

  • American City Business Journals27 days ago

    Report: AMRI considering $1 billion sale

    Drug manufacturer Albany Molecular Research Inc. is looking at a $1 billion sale, according to Bloomberg News. AMRI is working with Credit Suisse Group AG to explore a sale, Bloomberg reports, citing unidentified sources. Carlyle Group LP and Pamplona Capital Management, two private equity firms with records of investing in pharmaceutical and health care deals, have expressed interest.

  • 3 Biotech Stocks to Buy in March
    Motley Fool2 months ago

    3 Biotech Stocks to Buy in March

    Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great biotech stocks to buy as spring approaches.